Neuropsychiatric disturbances after stroke
Disorder | Prevalence | Main clinical characteristics | Adverse effects |
PSD | 13–57% |
| Associates with higher rates of stroke recurrence, lower quality of life and higher mortality3 |
PSAD | 6–90% |
| Increases the risk of future strokes, permanent loss of function and ultimately death4 |
PSA | 12–71% |
| Prevents patients from participating in rehabilitation programmes, resulting in delayed physical and social recovery6 |
PSF | 25–85% |
| Associates with shorter survival times, longer hospital stays, and higher rates of disability and mortality5 |
PSH | 6–44% |
| Important cause of disability and increase in recurrence of stroke7 |
PSI | 15–68% |
| Associates with depression, disability and fatigue, as well as a significant impact on return to work 1 year after stroke8 |
PSCI | 15–55% |
| Results in reduced quality of life and increased burden on families9 |
PSA, post-stroke apathy; PSAD, post-stroke anxiety disorder; PSCI, post-stroke cognitive impairment; PSD, post-stroke depression; PSF, post-stroke fatigue; PSH, post-stroke headache; PSI, post-stroke insomnia.